No matches
Dermatology

Understanding the Clinical Challenges and Underlying Pathomechanisms of Atopic Dermatitis and ​Prurigo Nodularis

Join experts Jason E. Hawkes, MD, MS and Douglas DiRuggiero, DMSc, MHS, PA-C at an ADVENT educational symposium at Elevate-Derm West Conference 2024 where they will discuss the diagnosis of atopic dermatitis and prurigo nodularis, how clinical signs and symptoms are driven by type 2 inflammation, and how early intervention has the potential to relieve the burden of these diseases on patients.
ADVENT at Elevate-Derm West
Past event
8November2024
Location
The Westin Kierland Resort
6902 E Greenway Pkwy, Scottsdale, AZ 85254

Symposium Details

November 8

Understanding the Clinical Challenges and Underlying Pathomechanisms of Atopic Dermatitis and ​Prurigo Nodularis

Join experts Jason E. Hawkes, MD, MS and Douglas DiRuggiero, DMSc, MHS, PA-Cat an ADVENT educational symposium at Elevate-Derm West Conference 2024 where they will discuss the diagnosis of atopic dermatitis and prurigo nodularis, how clinical signs and symptoms are driven by type 2 inflammation, and how early intervention has the potential to relieve the burden of these diseases on patients.

Learning objectives

  • Identify diagnostic considerations and challenges associated with atopic dermatitis (AD) and prurigo nodularis (PN)
  • Discuss the overall burden of AD and PN, and the importance of early intervention in AD
  • Highlight the overlapping role of type 2 inflammation in driving clinical signs and symptoms of both AD and PN

Location

The Westin Kierland Resort
6902 E Greenway Pkwy, Scottsdale, AZ 85254
Tags
symposium
MAT-US-2409937 v2.0 - P Exp Date: 10/08/2025

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region